Martin Hans Bohlin

Person

Macclesfield Cheshire, SE

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical formulation of odevixibat
- Patent number 11,802,115
- Issue date Oct 31, 2023
- Albireo AB
- Eva Byröd
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical formulation of odevixibat
- Patent number 11,801,226
- Issue date Oct 31, 2023
- Albireo AB
- Eva Byröd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solution phase synthesis of beta-turn peptidomimetic cyclic salts
- Patent number 11,753,441
- Issue date Sep 12, 2023
- Mimetogen Pharmaceuticals, Inc.
- Sébastien Rocchi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystal modifications of odevixibat
- Patent number 11,365,182
- Issue date Jun 21, 2022
- Albireo AB
- Robert Lundqvist
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solution phase synthesis and crystallization of beta-turn peptidomi...
- Patent number 11,078,234
- Issue date Aug 3, 2021
- Mimetogen Pharmaceuticals, Inc.
- Sébastien Rocchi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystal modifications of odevixibat
- Patent number 10,975,046
- Issue date Apr 13, 2021
- Albireo AB
- Robert Lundqvist
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystal modifications of elobixibat
- Patent number 10,519,120
- Issue date Dec 31, 2019
- Elobix AB
- Ingvar Ymén
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystal modifications of elobixibat
- Patent number 10,183,920
- Issue date Jan 22, 2019
- Elobix AB
- Ingvar Ymén
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solution phase synthesis and crystallization of beta-turn peptidomi...
- Patent number 10,125,165
- Issue date Nov 13, 2018
- MIMETOGEN PHARMACEUTICALS, INC.
- Sébastien Rocchi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystal modifications of elobixibat
- Patent number 9,745,276
- Issue date Aug 29, 2017
- Elobix AB
- Martin Bohlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal modifications of elobixibat
- Patent number 9,701,649
- Issue date Jul 11, 2017
- Elobix AB
- Martin Bohlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal modifications of elobixibat
- Patent number 9,409,875
- Issue date Aug 9, 2016
- Elobix AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline naloxol-PEG conjugate
- Patent number 9,149,539
- Issue date Oct 6, 2015
- Astrazeneca AB
- Bengt Aslund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for the preparation of crystalline modifications for use in...
- Patent number 8,658,799
- Issue date Feb 25, 2014
- Astrazeneca AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing [1S-[1-α, 2-α, 3-β(1S*,2R*) 5-β]]-3-[7-[2-(3,...
- Patent number 8,563,755
- Issue date Oct 22, 2013
- Astrazeneca AB
- Martin Hans Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of esomeprazole non-salt form
- Patent number 8,124,779
- Issue date Feb 28, 2012
- Astrazeneca AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-pe...
- Patent number 8,017,785
- Issue date Sep 13, 2011
- Astrazeneca AB
- Caroline Ericsson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process 054
- Patent number 7,816,545
- Issue date Oct 19, 2010
- Astrazeneca AB
- Rhony Aufdenblatten
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salts
- Patent number 7,763,597
- Issue date Jul 27, 2010
- Astrazeneca AB
- Matti Ahlqvist
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms
- Patent number 7,566,788
- Issue date Jul 28, 2009
- Astrazeneca AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salts
- Patent number 7,273,858
- Issue date Sep 25, 2007
- AstraZeneca AB
- Matti Ahlqvist
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cristalline and amorphous form of a triazolo (4,5-D) pyridimine com...
- Patent number 7,265,124
- Issue date Sep 4, 2007
- Astrazeneca AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process
- Patent number 6,747,155
- Issue date Jun 8, 2004
- Astrazeneca AB
- Anders Kronström
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of the S-enantiomer of omeprazole
- Patent number 6,162,816
- Issue date Dec 19, 2000
- AstraZeneca AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Pharmaceutical Formulation of Odevixibat
- Publication number 20240130976
- Publication date Apr 25, 2024
- ALBIREO AB
- Eva Byröd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATION OF ODEVIXIBAT
- Publication number 20240092748
- Publication date Mar 21, 2024
- ALBIREO AB
- Eva Byröd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLUTION PHASE SYNTHESIS OF BETA-TURN PEPTIDOMIMETIC CYCLIC SALTS
- Publication number 20230357318
- Publication date Nov 9, 2023
- Mimetogen Pharmaceuticals, Inc.
- Sébastien Rocchi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL MODIFICATIONS OF ODEVIXIBAT
- Publication number 20220281832
- Publication date Sep 8, 2022
- ALBIREO AB
- Robert Lundqvist
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLUTION PHASE SYNTHESIS OF BETA-TURN PEPTIDOMIMETIC CYCLIC SALTS
- Publication number 20210300966
- Publication date Sep 30, 2021
- Mimetogen Pharmaceuticals, Inc.
- Sébastien Rocchi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL FORMULATION OF ODEVIXIBAT
- Publication number 20210236511
- Publication date Aug 5, 2021
- ALBIREO AB
- Eva Byröd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATION OF ODEVIXIBAT
- Publication number 20210177767
- Publication date Jun 17, 2021
- ALBIREO AB
- Eva Byröd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTAL MODIFICATIONS OF ODEVIXIBAT
- Publication number 20210024475
- Publication date Jan 28, 2021
- ALBIREO AB
- Robert Lundqvist
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL MODIFICATIONS OF ODEVIXIBAT
- Publication number 20200002299
- Publication date Jan 2, 2020
- ALBIREO AB
- Robert Lundqvist
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLUTION PHASE SYNTHESIS AND CRYSTALLIZATION OF BETA-TURN PEPTIDOMI...
- Publication number 20190194251
- Publication date Jun 27, 2019
- Mimetogen Pharmaceuticals, Inc.
- Sébastien Rocchi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL MODIFICATIONS OF ELOBIXIBAT
- Publication number 20190177286
- Publication date Jun 13, 2019
- Elobix AB
- Ingvar Ymén
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL MODIFICATIONS OF ELOBIXIBAT
- Publication number 20170240516
- Publication date Aug 24, 2017
- Elobix AB
- Ingvar Ymén
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLUTION PHASE SYNTHESIS AND CRYSTALLIZATION OF BETA-TURN PEPTIDOMI...
- Publication number 20170008923
- Publication date Jan 12, 2017
- Mimetogen Pharmaceuticals, Inc.
- Sébastien Rocchi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL MODIFICATIONS OF ELOBIXIBAT
- Publication number 20160237049
- Publication date Aug 18, 2016
- Elobix AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL MODIFICATIONS OF ELOBIXIBAT
- Publication number 20160229822
- Publication date Aug 11, 2016
- Elobix AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL MODIFICATIONS OF ELOBIXIBAT
- Publication number 20160039777
- Publication date Feb 11, 2016
- Elobix AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE NALOXOL-PEG CONJUGATE
- Publication number 20150283257
- Publication date Oct 8, 2015
- AstraZeneca AB
- Bengt Aslund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE NALOXOL-PEG CONJUGATE
- Publication number 20150038524
- Publication date Feb 5, 2015
- ASTRAZENECA INTELLECTUAL PROPERTY
- Bengt Leonard Aslund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process For Preparing [1S-[1-alpha, 2-alpha, 3-beta (1S*,2R*) 5-bet...
- Publication number 20120101274
- Publication date Apr 26, 2012
- AstraZeneca AB
- Martin Hans Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process 054
- Publication number 20110009647
- Publication date Jan 13, 2011
- AstraZeneca AB
- Rhony Aufdenblatten
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Salt Forms Of (2S)-(4E)-N-Methyl-5-[3-(5-Isopropoxypyridin)yl...
- Publication number 20100249196
- Publication date Sep 30, 2010
- AstraZeneca AB
- Martin Hans Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839
- Publication number 20100137304
- Publication date Jun 3, 2010
- AstraZeneca AB
- John Peter GILDAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
New Crystalline Forms
- Publication number 20100022610
- Publication date Jan 28, 2010
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
New Process 054
- Publication number 20090182157
- Publication date Jul 16, 2009
- Rhony Aufdenblatten
- C07 - ORGANIC CHEMISTRY
Information Patent Application
New Salts
- Publication number 20080269176
- Publication date Oct 30, 2008
- AstraZeneca AB
- Matti Ahlqvist
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for the Preparation of Esomeprazole Non-Salt Form
- Publication number 20080269297
- Publication date Oct 30, 2008
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process For The Preparation Of Crystalline Modifications For Use In...
- Publication number 20080039503
- Publication date Feb 14, 2008
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cristalline and amorphous form of a triazolo (4,5-d) pyridimine com...
- Publication number 20070293513
- Publication date Dec 20, 2007
- AstraZeneca AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystalline Forms
- Publication number 20070225346
- Publication date Sep 27, 2007
- AstraZeneca AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRISTALLINE AND AMORPHOUS FORM OF A TRIAZOLO (4,5-D) PYRIDIMINE COM...
- Publication number 20070173518
- Publication date Jul 26, 2007
- AstraZeneca AB
- Martin Bohlin
- C07 - ORGANIC CHEMISTRY

Martin Hans Bohlin

Person

Patents Grantslast 30 patents

Pharmaceutical formulation of odevixibat

Pharmaceutical formulation of odevixibat

Solution phase synthesis of beta-turn peptidomimetic cyclic salts

Crystal modifications of odevixibat

Solution phase synthesis and crystallization of beta-turn peptidomi...

Crystal modifications of odevixibat

Crystal modifications of elobixibat

Crystal modifications of elobixibat

Solution phase synthesis and crystallization of beta-turn peptidomi...

Crystal modifications of elobixibat

Crystal modifications of elobixibat

Crystal modifications of elobixibat

Crystalline naloxol-PEG conjugate

Process for the preparation of crystalline modifications for use in...

Process for preparing [1S-[1-α, 2-α, 3-β(1S*,2R*) 5-β]]-3-[7-[2-(3,...

Process for the preparation of esomeprazole non-salt form

Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-pe...

Process 054

Salts

Crystalline forms

Salts

Cristalline and amorphous form of a triazolo (4,5-D) pyridimine com...

Process

Crystalline form of the S-enantiomer of omeprazole

Patents Applicationslast 30 patents

Pharmaceutical Formulation of Odevixibat

PHARMACEUTICAL FORMULATION OF ODEVIXIBAT

SOLUTION PHASE SYNTHESIS OF BETA-TURN PEPTIDOMIMETIC CYCLIC SALTS

CRYSTAL MODIFICATIONS OF ODEVIXIBAT

SOLUTION PHASE SYNTHESIS OF BETA-TURN PEPTIDOMIMETIC CYCLIC SALTS

PHARMACEUTICAL FORMULATION OF ODEVIXIBAT

PHARMACEUTICAL FORMULATION OF ODEVIXIBAT

CRYSTAL MODIFICATIONS OF ODEVIXIBAT

CRYSTAL MODIFICATIONS OF ODEVIXIBAT

SOLUTION PHASE SYNTHESIS AND CRYSTALLIZATION OF BETA-TURN PEPTIDOMI...

CRYSTAL MODIFICATIONS OF ELOBIXIBAT

CRYSTAL MODIFICATIONS OF ELOBIXIBAT

SOLUTION PHASE SYNTHESIS AND CRYSTALLIZATION OF BETA-TURN PEPTIDOMI...

CRYSTAL MODIFICATIONS OF ELOBIXIBAT

CRYSTAL MODIFICATIONS OF ELOBIXIBAT

CRYSTAL MODIFICATIONS OF ELOBIXIBAT

CRYSTALLINE NALOXOL-PEG CONJUGATE

CRYSTALLINE NALOXOL-PEG CONJUGATE

Process For Preparing [1S-[1-alpha, 2-alpha, 3-beta (1S*,2R*) 5-bet...

Process 054

Novel Salt Forms Of (2S)-(4E)-N-Methyl-5-[3-(5-Isopropoxypyridin)yl...

NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839

New Crystalline Forms

New Process 054

New Salts

Process for the Preparation of Esomeprazole Non-Salt Form

Process For The Preparation Of Crystalline Modifications For Use In...

Cristalline and amorphous form of a triazolo (4,5-d) pyridimine com...

Crystalline Forms

CRISTALLINE AND AMORPHOUS FORM OF A TRIAZOLO (4,5-D) PYRIDIMINE COM...

Process for preparing [1S-[1-α, 2-α, 3-β(1S,2R) 5-β]]-3-[7-[2-(3,...

Process For Preparing [1S-[1-alpha, 2-alpha, 3-beta (1S,2R) 5-bet...